You are here: Welcome » Jessica Hopkins

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
jessica_hopkins [2022/01/06 11:35]
liam 		jessica_hopkins [2022/01/30 01:08] (current)
liam [Ontario COVID-19 Science Advisory Table]
Line 17: Line 17:
 ==== Ontario COVID-19 Science Advisory Table ==== ==== Ontario COVID-19 Science Advisory Table ====
  
-Hopkins is a member of the [[COVID-19 Science Advisory Table]]. In this capacity, Hopkins urged parents to inject their children with a [[COVID-19]] product as soon as they were approved by the [[National Advisory Committee on Immunization]] (NACI), as well as all of their caregivers.((Cross, J. S. (2021, August 26). //Public Health Ontario urging parents to immunize young children against COVID-19 as soon as vaccines are approved.// QP Briefing. https://www.qpbriefing.com/2021/08/26/public-health-ontario-urging-parents-to-immunize-young-children-against-covid-19-as-soon-as-vaccines-are-approved/))+Hopkins is a member of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved January 29, 2022, from https://covid19-sciencetable.ca/about/#hopkins-jessica)) In this capacity, Hopkins urged parents to inject their children with a [[COVID-19]] product as soon as they were approved by the [[National Advisory Committee on Immunization]] (NACI), as well as all of their caregivers.((Cross, J. S. (2021, August 26). //Public Health Ontario urging parents to immunize young children against COVID-19 as soon as vaccines are approved.// QP Briefing. https://www.qpbriefing.com/2021/08/26/public-health-ontario-urging-parents-to-immunize-young-children-against-covid-19-as-soon-as-vaccines-are-approved/))
  
 ==== Ontario Medical Association ==== ==== Ontario Medical Association ====
Line 41: Line 41:
   * //Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results.//((Gubbay, J. B., Rilkoff, H., Kristjanson, H. L., Forbes, J. D., Murti, M., Eshaghi, A., Broukhanski, G., Corbeil, A., Fittipaldi, N., Hopkins, J. P., Kristjanson, E., Kus, J. V., Macdonald, L., Majury, A., Mallo, G. V., Mazzulli, T., Melano, R. G., Olsha, R., Perusini, S. J., & Tran, V. (2021). //Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results.// Infection Control & Hospital Epidemiology, 1–18. https://doi.org/10.1017/ice.2021.369))   * //Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results.//((Gubbay, J. B., Rilkoff, H., Kristjanson, H. L., Forbes, J. D., Murti, M., Eshaghi, A., Broukhanski, G., Corbeil, A., Fittipaldi, N., Hopkins, J. P., Kristjanson, E., Kus, J. V., Macdonald, L., Majury, A., Mallo, G. V., Mazzulli, T., Melano, R. G., Olsha, R., Perusini, S. J., & Tran, V. (2021). //Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results.// Infection Control & Hospital Epidemiology, 1–18. https://doi.org/10.1017/ice.2021.369))
     * Conclusion: “Large-scale SARS-CoV-2 screening testing initiatives among low pre-test probability populations [patients who are not symptomatic and/or don’t have a confirmed contact with a person sick with COVID-19] should be evaluated thoroughly prior to implementation given the risk of false positives and consequent potential for harm at the individual and population level.”     * Conclusion: “Large-scale SARS-CoV-2 screening testing initiatives among low pre-test probability populations [patients who are not symptomatic and/or don’t have a confirmed contact with a person sick with COVID-19] should be evaluated thoroughly prior to implementation given the risk of false positives and consequent potential for harm at the individual and population level.”
-  * S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021 +  * //S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021//((Brown, K. A., Gubbay, J., Hopkins, J., Patel, S., Buchan, S. A., Daneman, N., & Goneau, L. W. (2021). //S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021.// JAMA, 325(20), 2115. https://doi.org/10.1001/jama.2021.5607)) 
-  * The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada +  * //The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada//((Maharaj, A. S., Parker, J., Hopkins, J. P., Gournis, E., Bogoch, I. I., Rader, B., Astley, C. M., Ivers, N., Hawkins, J. B., VanStone, N., Tuite, A. R., Fisman, D. N., Brownstein, J. S., & Lapointe-Shaw, L. (2021). //The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada.// The Lancet Infectious Diseases, 21(5), 593–594. https://doi.org/10.1016/s1473-3099(21)00151-1)) 
-    * Funded by the Department of Medicine COVID-19 Funding Opportunity from the University of Toronto +    * Funded by the Department of Medicine COVID-19 Funding Opportunity from the [[University of Toronto]] 
-  * Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy +  * //Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy//((Mustafa, R. A., Santesso, N., Khatib, R., Mustafa, A. A., Wiercioch, W., Kehar, R., Gandhi, S., Chen, Y., Cheung, A., Hopkins, J., Ma, B., Lloyd, N., Wu, D., Broutet, N., & Schünemann, H. J. (2016). //Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy.// International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 132(3), 259–265. https://doi.org/10.1016/j.ijgo.2015.07.024)) 
-    * Commissioned and funded by the World Health Organization (WHO) +    * Commissioned and funded by the [[World Health Organization]] (WHO) 
-  * Antivirals for Treatment of Influenza: A Systematic Review and Meta-analysis of Observational Studies +  * //Antivirals for Treatment of Influenza: A Systematic Review and Meta-analysis of Observational Studies//((Hsu, J., Santesso, N., Mustafa, R., Brozek, J., Chen, Y. L., Hopkins, J. P., Cheung, A., Hovhannisyan, G., Ivanova, L., Flottorp, S. A., Sæterdal, I., Wong, A. D., Tian, J., Uyeki, T. M., Akl, E. A., Alonso-Coello, P., Smaill, F., & Schünemann, H. J. (2012). //Antivirals for Treatment of Influenza.// Annals of Internal Medicine, 156(7), 512. https://doi.org/10.7326/0003-4819-156-7-201204030-00411)) 
-    * Funded by the World Health Organization (WHO) and McMaster University +    * Funded by the [[World Health Organization]] (WHO) and [[McMaster University]] 
-  * Evaluation of the ability of standardized supports to improve public health response to syndromic surveillance for respiratory diseases in Canada +  * //Evaluation of the ability of standardized supports to improve public health response to syndromic surveillance for respiratory diseases in Canada//((Rivera, L. A., Li, Y., Savage, R. D., Crowcroft, N. S., Bolotin, S., Rosella, L. C., Lou, W., Hopkins, J., Gemmill, I., & Johnson, I. (2017). //Evaluation of the ability of standardized supports to improve public health response to syndromic surveillance for respiratory diseases in Canada.// BMC Public Health, 17(1). https://doi.org/10.1186/s12889-017-4073-6)) 
-    * Funded by the Canadian Institutes of Health Research (CIHR) +    * Funded by the [[Canadian Institutes of Health Research]] (CIHR) 
-  * World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen-and-treat strategies to prevent cervical cancer +  * //World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen-and-treat strategies to prevent cervical cancer//((Santesso, N., Mustafa, R. A., Schünemann, H. J., Arbyn, M., Blumenthal, P. D., Cain, J., Chirenje, M., Denny, L., De Vuyst, H., Eckert, L. O., Forhan, S. E., Franco, E. L., Gage, J. C., Garcia, F., Herrero, R., Jeronimo, J., Lu, E. R., Luciani, S., Quek, S. C., & Sankaranarayanan, R. (2016). //World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.// International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 132(3), 252–258. https://doi.org/10.1016/j.ijgo.2015.07.038)) 
-    * Funded by the World Health Organization (WHO), Flanders International Cooperation Agency, Institut National du Cancer (National Cancer Institute in France), and Gavi, the Vaccine Alliance+    * Funded by the [[World Health Organization]] (WHO), [[Flanders International Cooperation Agency]], [[Institut National du Cancer]] (National Cancer Institute in France), and [[gavi|Gavi, the Vaccine Alliance]]
  
Back to top